PL380408A1 - Nowy proces syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli - Google Patents
Nowy proces syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soliInfo
- Publication number
- PL380408A1 PL380408A1 PL380408A PL38040804A PL380408A1 PL 380408 A1 PL380408 A1 PL 380408A1 PL 380408 A PL380408 A PL 380408A PL 38040804 A PL38040804 A PL 38040804A PL 380408 A1 PL380408 A1 PL 380408A1
- Authority
- PL
- Poland
- Prior art keywords
- perindopril
- synthesising
- pharmaceutically
- acceptable salts
- novel method
- Prior art date
Links
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title 1
- 229960002582 perindopril Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03291601A EP1367061B1 (fr) | 2003-06-30 | 2003-06-30 | Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
| PCT/FR2004/001637 WO2005003153A1 (fr) | 2003-06-30 | 2004-06-28 | Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL380408A1 true PL380408A1 (pl) | 2007-01-22 |
| PL211161B1 PL211161B1 (pl) | 2012-04-30 |
Family
ID=29414888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL380408A PL211161B1 (pl) | 2003-06-30 | 2004-06-28 | Sposób wytwarzania perindoprilu i jego farmaceutycznie dopuszczalnych soli |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7179833B2 (pl) |
| EP (1) | EP1367061B1 (pl) |
| JP (1) | JP4347341B2 (pl) |
| CN (1) | CN1802384B (pl) |
| AR (1) | AR044944A1 (pl) |
| AT (1) | ATE315043T1 (pl) |
| AU (1) | AU2004253721B2 (pl) |
| DE (1) | DE60303101T2 (pl) |
| DK (1) | DK1367061T3 (pl) |
| EA (1) | EA008836B1 (pl) |
| ES (1) | ES2256689T3 (pl) |
| MY (1) | MY139159A (pl) |
| NZ (1) | NZ544003A (pl) |
| PL (1) | PL211161B1 (pl) |
| SI (1) | SI1367061T1 (pl) |
| WO (1) | WO2005003153A1 (pl) |
| ZA (1) | ZA200510330B (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2286393T3 (es) * | 2003-06-30 | 2007-12-01 | Les Laboratoires Servier | Nuevo procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables. |
| EP1380591B1 (fr) * | 2003-08-29 | 2005-11-16 | Les Laboratoires Servier | Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
| SI21800A (sl) * | 2004-05-14 | 2005-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze perindoprila |
| US7615571B2 (en) * | 2004-05-31 | 2009-11-10 | Ipca Laboratories Ltd. | Process for manufacture of pure (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl]amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid and its tert. butyl amine salt |
| JP5133061B2 (ja) * | 2004-10-20 | 2013-01-30 | エシコン・インコーポレイテッド | 強化された吸収性複層の止血用創傷手当て用品および製造方法 |
| US9358318B2 (en) * | 2004-10-20 | 2016-06-07 | Ethicon, Inc. | Method of making a reinforced absorbable multilayered hemostatic wound dressing |
| EP1679072B9 (en) | 2005-01-06 | 2009-09-02 | IPCA Laboratories Limited | Process for for synthesis of (2S,3aS,7aS)-1-(S)-alanyl-octahydro-1H-indole-2- carboxylic acid derivatives and use in the synthesis of perindopril |
| US7291745B2 (en) | 2005-03-21 | 2007-11-06 | Glenmark Pharmaceuticals Limited | Process for the preparation of perindopril |
| JP2008019214A (ja) * | 2006-07-13 | 2008-01-31 | Shiono Chemical Co Ltd | ペリンドプリルまたはその誘導体の製造方法 |
| RU2433998C1 (ru) * | 2010-03-16 | 2011-11-20 | Закрытое акционерное общество "Активный Компонент" | Способ получения периндоприла и его фармацевтически приемлемых солей |
| WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
| PH12018502155B1 (en) | 2016-04-20 | 2024-03-27 | Servier Lab | Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2503155A2 (fr) * | 1980-10-02 | 1982-10-08 | Science Union & Cie | Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
| SI9500140A (en) * | 1995-04-24 | 1996-10-31 | Genesis Para La Investigacion | Novel n-sulfoxy anhydrides, process for the preparation thereof and its use for the preparation of bioactive substances having ace inhibitory action |
| ES2240919T3 (es) * | 2003-03-12 | 2005-10-16 | Les Laboratoires Servier | Nuevo procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables. |
| US20050171165A1 (en) * | 2003-11-12 | 2005-08-04 | Bhirud Shekhar B. | Process for the preparation of perindopril |
-
2003
- 2003-06-30 DE DE60303101T patent/DE60303101T2/de not_active Expired - Lifetime
- 2003-06-30 SI SI200330154T patent/SI1367061T1/sl unknown
- 2003-06-30 ES ES03291601T patent/ES2256689T3/es not_active Expired - Lifetime
- 2003-06-30 DK DK03291601T patent/DK1367061T3/da active
- 2003-06-30 AT AT03291601T patent/ATE315043T1/de active
- 2003-06-30 EP EP03291601A patent/EP1367061B1/fr not_active Expired - Lifetime
-
2004
- 2004-06-28 ZA ZA200510330A patent/ZA200510330B/xx unknown
- 2004-06-28 EA EA200501925A patent/EA008836B1/ru not_active IP Right Cessation
- 2004-06-28 AU AU2004253721A patent/AU2004253721B2/en not_active Ceased
- 2004-06-28 CN CN2004800160147A patent/CN1802384B/zh not_active Expired - Fee Related
- 2004-06-28 PL PL380408A patent/PL211161B1/pl unknown
- 2004-06-28 US US10/562,490 patent/US7179833B2/en not_active Expired - Fee Related
- 2004-06-28 WO PCT/FR2004/001637 patent/WO2005003153A1/fr not_active Ceased
- 2004-06-28 JP JP2006515295A patent/JP4347341B2/ja not_active Expired - Fee Related
- 2004-06-28 NZ NZ544003A patent/NZ544003A/en not_active IP Right Cessation
- 2004-06-28 MY MYPI20042540A patent/MY139159A/en unknown
- 2004-06-29 AR ARP040102277A patent/AR044944A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1367061B1 (fr) | 2006-01-04 |
| CN1802384B (zh) | 2010-06-16 |
| WO2005003153A1 (fr) | 2005-01-13 |
| PL211161B1 (pl) | 2012-04-30 |
| JP2007537974A (ja) | 2007-12-27 |
| EA008836B1 (ru) | 2007-08-31 |
| AU2004253721B2 (en) | 2007-12-20 |
| AU2004253721A1 (en) | 2005-01-13 |
| ZA200510330B (en) | 2007-05-30 |
| US20060178421A1 (en) | 2006-08-10 |
| ATE315043T1 (de) | 2006-02-15 |
| EA200501925A1 (ru) | 2006-06-30 |
| DE60303101D1 (de) | 2006-03-30 |
| DK1367061T3 (da) | 2006-05-15 |
| SI1367061T1 (sl) | 2006-04-30 |
| NZ544003A (en) | 2009-03-31 |
| ES2256689T3 (es) | 2006-07-16 |
| DE60303101T2 (de) | 2006-09-28 |
| EP1367061A1 (fr) | 2003-12-03 |
| MY139159A (en) | 2009-08-28 |
| US7179833B2 (en) | 2007-02-20 |
| JP4347341B2 (ja) | 2009-10-21 |
| AR044944A1 (es) | 2005-10-12 |
| CN1802384A (zh) | 2006-07-12 |
| HK1089188A1 (en) | 2006-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL165584A0 (en) | Novel formate salt of o-desmethyl-venlafaxine | |
| ZA200510330B (en) | Novel method of synthesising perindopril and the pharmaceutically-acceptable salts thereof | |
| EG26629A (en) | A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts | |
| EG24152A (en) | Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril | |
| ZA200510324B (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| ZA200601426B (en) | Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof | |
| PL379629A1 (pl) | Nowy sposób syntezy perindoprylu oraz jego farmaceutycznie dopuszczalnych soli | |
| PL379628A1 (pl) | Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli | |
| PL380410A1 (pl) | Sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli | |
| SI1753720T1 (sl) | Postopek za pripravo perindoprila in njegovih soli | |
| MXPA02004180A (es) | Metodos de sintesis de dl-hidroxi-alquil-fenil amidas. | |
| ZA200505779B (en) | Novel method for synthesising (2S,3AS,7AS)-perhydroin-dole-2-carboxylic acid and the sters thereof and the use thereof for perindopril synthesis | |
| SI1403275T1 (sl) | Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli | |
| PL379625A1 (pl) | Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli | |
| PL379631A1 (pl) | Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli | |
| AU2003276825A8 (en) | Method of immunotherapy | |
| SI1422236T1 (sl) | Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli | |
| EP1592780A4 (en) | DYRKS AS MODIFIERS OF APC AND AXIN PATHWAYS AND METHODS OF USE | |
| AU2003228532A8 (en) | Methods of use of the enzymes of mycothiol synthesis | |
| PL357664A1 (pl) | Sposób modyfikacji cząsteczki chemicznej | |
| AU2002357536A1 (en) | Method for synthesising diamond with the aid of magnetic monofields | |
| GB0207105D0 (en) | Methods of synthesising organofluorine compounds | |
| EP1508623A4 (en) | METHOD FOR SPECIFYING SINGLE NUCLEOTIDE POLYMORPHISM (SNP) | |
| GB0209409D0 (en) | Growing medium | |
| PL114097U1 (en) | Acoustic shield of the cooling tower |